Amcinonide

Amcinonide

SCHEMBL4134632

CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C.CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

NR3C1

The experimentally established mechanism targets of Amcinonide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 known ✓ P04150 7/20 0.66
▸ USP2 O75604 7/20 0.66
▸ CYP3A4 P08684 7/20 0.66
▸ PGR P06401 6/20 0.66
▸ LMNA P02545 5/20 0.66
▸ HIF1A Q16665 5/20 0.66
▸ CNR1 P21554 4/20 0.66
▸ MAPT P10636 3/20 0.66
▸ NPSR1 Q6W5P4 2/20 0.66
▸ KCNH2 Q12809 1/20 0.66
▸ CYP2C9 P11712 3/20 0.63
▸ KDM4E B2RXH2 1/20 0.63
▸ ALDH1A1 P00352 1/20 0.63
▸ TDP1 Q9NUW8 1/20 0.63
▸ NR1I2 O75469 2/20 0.62
▸ ADORA3 P0DMS8 2/20 0.62
▸ DRD2 P14416 1/20 0.62
▸ OPRD1 P41143 1/20 0.62
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ MLNR O43193 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amcinonide SCHEMBL8420886 0.91 CYP3A4 (0.80) USP2NR3C1CYP3A4PGRLMNA
Betamethasone Dipropionate SCHEMBL7120868 0.82 NR3C1 (0.68) USP2NR3C1CYP3A4PGRLMNA
Amcinonide SCHEMBL1649481 0.81 HIF1A (1.00) USP2NR3C1CYP3A4PGRLMNA
Amcinonide SCHEMBL4720 0.81 HIF1A (1.00) USP2NR3C1CYP3A4PGRLMNA
Amcinonide SCHEMBL21051752 0.81 HIF1A (1.00) USP2NR3C1CYP3A4PGRLMNA
Amcinonide SCHEMBL13026154 0.81 HIF1A (1.00) USP2NR3C1CYP3A4PGRLMNA
Amcinonide SCHEMBL5488922 0.81 HIF1A (1.00) USP2NR3C1CYP3A4PGRLMNA
Amcinonide SCHEMBL12396698 0.81 HIF1A (1.00) USP2NR3C1CYP3A4PGRLMNA
Betamethasone Dipropionate SCHEMBL3048282 0.81 NR3C1 (0.79) USP2NR3C1CYP3A4PGRLMNA
SCHEMBL25370010 0.80 NR3C1 (0.91) USP2NR3C1CYP3A4PGRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106278999-B S1P regulator 比奥根MA公司 2019-10-25 — — CN disclosed
CN-106278999-A S1p regulator 比奥根MA公司 2017-01-04 — — CN disclosed
CN-103533835-B S1P modulators 比奥根MA公司 2016-08-24 — — CN disclosed
US-20090075958-A1 CLOBETASOL PROPIONATE SHAMPOOS FOR THE TREATMENT OF SEBORRHEIC DERMATITIS OF THE SCALP BISTUER FLORENCE 2009-03-19 — — US disclosed
US-20080275014-A1 Clobetasol Propionate Shampoos for the Treatment of Seborrheic Dermatitis of the Scalp GALDERMA S.A. (CH) 2008-11-06 — — US disclosed
EP-1824448-A1 CLOBETASOL PROPIONATE SHAMPOOS FOR THE TREATMENT OF SEBORRHEIC DERMATITIS OF THE SCALP Galderma S.A. (CH) 2007-08-29 — — EP disclosed
US-20060134055-A1 Clobetasol propionate shampoos for the treatment of seborrheic dermatitis of the scalp GALDERMA S.A. (CH) 2006-06-22 — — US disclosed
WO-2006061260-A1 CLOBETASOL PROPIONATE SHAMPOOS FOR THE TREATMENT OF SEBORRHEIC DERMATITIS OF THE SCALP GALDERMA S.A. (CH) 2006-06-15 — — WO disclosed
Send feedback